Related Experiment Video
Updated: Jun 17, 2025

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
Published on: September 6, 2024
The Pneumothorax And Symptom Evaluation (PASE) study: Bendopnoea in patients with pneumothorax
Bianca M Iacopetta1,2, Michaela Donaghy3, Chloe Charlesworth3
1Pleural Medicine Unit Institute for Respiratory Health Perth Western Australia Australia.
Background:
Pneumothorax can cause distressing breathlessness, however the effect of the accumulated air in the pleural space and its association with diaphragmatic function and symptoms of breathlessness is not well understood. Bendopnoea is an evolving clinical symptom that has been demonstrated as clinically useful in some heart and lung conditions. Whether bendopnoea is present in patients with pneumothorax, and its potential clinical usefulness has not yet been investigated. The PASE study is a pilot study to explore the incidence and clinical relevance of bendopnoea in patients with pneumothorax and may provide better understanding of pneumothorax related dyspnoea.
Methods:
PASE is a prospective study. Eligible patients are assessed at baseline (pre air drainage/lung reinflation) and in patients whose pneumothorax resolves once the lung has re-expanded (post conservative management or air drainage procedure). Outcome measures include the incidence of bendopnoea, correlation of the associated symptoms (pain and breathlessness) to the severity of bendopnoea and the size of pneumothorax; and correlation with clinical outcome (i.e., response to air drainage/lung reinflation). The study will recruit 50 participants.
Discussion:
This is the first study to explore bendopnoea in patients with pneumothorax. The presence and significance of bendopnoea in relation to clinical and physiological parameters in patients with pneumothorax requires investigation. The findings of this study may further current understanding of dyspnoea related pneumothorax.
Trial Registration:
Australia New Zealand Clinical Trial Registry : ACTRN12623001109695p. : https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=386631&isReview=true : Registered on 24 October 2023. : This study has not received grant support. The study is sponsored by the Institute for Respiratory Health, a not-for-profit organisation. : Mr Bi Lam; Finance manager. Level 2, 6 Verdun Street, Nedlands, WA 6009. : The funder is not involved in the planning of the study, gathering, analysing, and interpreting the data, or in preparing the manuscript. : 1.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Pneumonia III: Complications and Assessment
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

